Not applicableUnknownNCT03582865What this trial is testingGenetic Study of CYP2D6 Enzyme and Therapeutic Drug Monitoring of TamoxifenWho this might be right forBreast Cancer Assiut University 100
Post-approval studies (Phase 4)Study completedNCT01403532What this trial is testingSequential Therapy for Hypogonadotropic HypogonadismWho this might be right forHypogonadotropic HypogonadismKallmann Syndrome Shanghai Jiao Tong University School of Medicine 100
Large-scale testing (Phase 3)Active Not RecruitingNCT06073132What this trial is testingAn International, Multicenter, Randomized, Double-Blind, Parallel Group, Vehicle-Controlled, Phase 2/3 Study With Open-Label Extension Evaluating the Efficacy and Safety of Diacerein 1% Ointment for the Treatment of Generalized Epidermolysis Bullosa Simplex (EBS)Who this might be right forGeneralized Epidermolysis Bullosa Simplex TWi Biotechnology, Inc. 80
Not applicableStudy completedNCT02464293What this trial is testingA Pilot Evaluation of Mindfulness-based Cognitive Therapy for People With Huntington's DiseaseWho this might be right forHuntington Disease Lancaster University 16
Large-scale testing (Phase 3)Study completedNCT01641393What this trial is testingSafety and Efficacy Study of 2 Pancreatic Enzymes for Treatment of Exocrine Pancreatic Insufficiency in Cystic Fibrosis.Who this might be right forExocrine Pancreatic Insufficiency: Cystic Fibrosis Forest Laboratories 96
Early research (Phase 1)Study completedNCT00003107What this trial is testingInterleukin-12 in Treating Patients With Hematologic Cancers or Solid TumorsWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+8 more Indiana University
Not applicableEnded earlyNCT03056144What this trial is testingWhole Body Vibration Therapy in Children With Spinal Muscular AtrophyWho this might be right forSpinal Muscular Atrophy Type 3 The Hong Kong Polytechnic University 1
Not applicableStudy completedNCT01920464What this trial is testingPlace of Flixovate® in the Treatment Pathway and Its Conditions of Use in Infants Aged From 3 to 12 Months Between 2010 and 2012 by French GPs and Private PaediatriciansWho this might be right forDermatitis, Atopic GlaxoSmithKline 160
Testing effectiveness (Phase 2)Study completedNCT03041909What this trial is testingAn Extension Study to Further Evaluate the Safety, Tolerability of GBT440 in Patients With Sickle Cell Disease Who Participated in the Study GBT440-001Who this might be right forSickle Cell Disease Global Blood Therapeutics 5
Post-approval studies (Phase 4)Not Yet RecruitingNCT03892330What this trial is testingCombination Therapy of Anthracyclines for Children With NephroblastomaWho this might be right for0.5-14 Year Old Children With Nephroblastoma Shengjing Hospital 120
Not applicableStudy completedNCT03462511What this trial is testingHydroxyurea Adherence for Personal Best in Sickle Cell Disease (HABIT): Efficacy TrialWho this might be right forSickle Cell Disease Columbia University 50
Testing effectiveness (Phase 2)UnknownNCT00884767What this trial is testingBiomarkers in Predicting Neurotoxicity in Patients With Colorectal Cancer Receiving OxaliplatinWho this might be right forChemotherapeutic Agent ToxicityColorectal CancerNeurotoxicity Institut Cancerologie de l'Ouest 206
Early research (Phase 1)Study completedNCT01682811What this trial is testingPhase I Photodynamic Therapy (PDT) for Benign Dermal Neurofibromas (NF1)Who this might be right forNeurofibromatoses Harry T Whelan, MD 20
Testing effectiveness (Phase 2)Study completedNCT05485987What this trial is testingVatiquinone for the Treatment of Participants With Friedreich AtaxiaWho this might be right forFriedreich Ataxia PTC Therapeutics 5
Not applicableLooking for participantsNCT07248267What this trial is testingEffects of Vojta Therapy on Functional Mobility and Gait Parameters in Children With Down SyndromeWho this might be right forDown Syndrome Riphah International University 28
Testing effectiveness (Phase 2)Looking for participantsNCT05791864What this trial is testingA First-in-Human, Open-Label, Dose-Escalation Study to Evaluate the Safety and Tolerability of Gene Therapy With TTX-381 for the Ocular Manifestations Associated With Neuronal Ceroid Lipofuscinosis Type 2 (CLN2) DiseaseWho this might be right forNeuronal Ceroid Lipofuscinosis Type 2 Tern Therapeutics, LLC 16
Not applicableLooking for participantsNCT07421219What this trial is testingARTEMIS - The ARTEMIS CohortWho this might be right forNon-progressive Congenital AtaxiaAtaxic Cerebral Palsy Vastra Gotaland Region 50
Testing effectiveness (Phase 2)Study completedNCT01412892What this trial is testingUse of RAD001 as Monotherapy in the Treatment of Neurofibromatosis 1 Related Internal Plexiform NeurofibromasWho this might be right forNeurofibromatosis Type 1Plexiform NeurofibromaNeurofibromatoses Assistance Publique - Hôpitaux de Paris 30
Early research (Phase 1)Study completedNCT00020267What this trial is testingVaccine Therapy in Treating Patients With Metastatic CancerWho this might be right forLung CancerAdult Soft Tissue SarcomaColorectal Cancer+8 more National Cancer Institute (NCI)
Not applicableUnknownNCT01106144What this trial is testingGenetic Predictive Model Based on Single Nucleotide Polymorphisms in the DNA Repair Pathway and Drug Metabolis/Transport Pharmacogenetics in the Prediction of Response and Treatment Outcomes in Acute Myeloid LeukemiaWho this might be right forPatients With Acute Myeloid LeukemiaPatients Receiving Induction/Consolidation Chemotherapy Samsung Medical Center 500